Skip to main content
Clinical Trials/ISRCTN15615992
ISRCTN15615992
Completed
未知

europsychological Evaluation and Rehabilitation in Multiple Sclerosis (NEuRoMS): refining the screening and management pathway in routine clinical practice (Phase 1: Work Package 2ii Qualitative Study)

ottinghamshire Healthcare NHS Foundation Trust0 sites31 target enrollmentFebruary 23, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple sclerosis
Sponsor
ottinghamshire Healthcare NHS Foundation Trust
Enrollment
31
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2021
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ottinghamshire Healthcare NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. People with MS:
  • 1\.1\. Diagnosis of MS
  • 2\.2\. Received neuropsychological screening and mild cognitive problems identified (in WP2i IRAS ID: 276570\)
  • 2\. Related informants:
  • 2\.1\. Relative or carer supporting a person with MS
  • 3\. Clinicians:
  • 3\.1\. Health professionals (e.g., neurologists, MS nurse specialists, psychologists, occupational therapists) delivering the NEuRoMS screening and management pathway to people with MS
  • 4\. Intervention providers:
  • 4\.1\. Research nurses/assistant psychologists delivering the intervention to people with MS identified above in 1
  • All individuals:

Exclusion Criteria

  • 1\. Do not have the mental capacity to consent to take part in the study
  • 2\. Are unable to communicate in English (standardised materials are to be used which have not yet been developed for other groups)

Outcomes

Primary Outcomes

Not specified

Similar Trials